Looks like David Einhorn has scored another victory. No, not on the Buzz Lightyear-like Apple gains, a stock Einhorn has been adding to.
But on Aetna's $5.7bn deal for Coventry, which has Einhorn's big bet on healthcare insurers in the second quarter looking lucrative.